BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

ASRT: ASEG Guideline a Significant Positive, PT to $8

ASRT: Convertible Offering Pauses Momentum

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>ASRT issued preliminary fourth quarter 2022 results highlighting the continued growth in revenue. We assume the increase in revenue was due to uplift in Indocin usage in the quarter.</li>
<li>Heading into 2023, ASRT is carrying a larger than expected cash balance to deploy in making acquisitions</li>
<li>ASRT is forecasting fourth quarter sales of $49 to $50 million compared to our estimate of $47.1 million</li>
</ul>


ASRT issued preliminary fourth quarter 2022 results highlighting the continued growth in revenue. We assume the increase in revenue was due to uplift in Indocin usage in the quarter.
Heading into 2023, ASRT is carrying a larger than expected cash balance to deploy in making acquisitions
ASRT is forecasting fourth quarter sales of $49 to $50 million compared to our estimate of $47.1 million


ASRT: Updated Q4 Results Puts 2023 in Focus

Assertio Holdings

ASRT: Updated Q4 Results Puts 2023 in Focus